Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
Date:2/20/2008

assets and liabilities (3,181) (3,808)

Total adjustments 286,148 916,370

Net cash provided by

operating activities 427,178 471,365

Cash Flows from Investing Activities:

Additions to property, equipment and

product rights (75,870) (45,028)

Acquisition of business, net of cash

acquired - (1,558,322)

Additions to marketable securities

and long-term investments (8,451) (18,835)

Proceeds from sale of marketable

securities and investments 4,113 158,185

Other investing activities, net 15,916 44,581

Net cash used in investing

activities (64,292) (1,419,419)

Cash Flows from Financing Activities:

Proceeds from issuance of long-term debt - 650,000

Payments on term loan, current debt

and other long-term liabilities (329,532) (23,363)

Proceeds from stock plans 16,160 8,137

Other 869 -

Net cash (used in) provided

by financing activities (312,503) 634,774

Net increase (decrease) in

cash and cash equivalents 50,383 (313,280)

Cash and cash equivalents at

beginning of period 154,171 467,451

Cash and cash equivalents at end of

period $204,554 $154,171

The following table presents a reconciliation of reported net income and diluted earnings per diluted share
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Watson Receives FDA Approval for Generic Accuneb(R)
4. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
8. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Sky One,Medical, Inc. ("China Sky One Medical" or ... integrated pharmaceutical company developing and producing,over-the-counter drugs in ... the Company has 30 medicines that will be ... Medical Insurance, Industrial Injury Insurance,and Maternity Insurance Medicine ... medicines treat a variety of common ailments and ...
(Date:12/15/2009)... Dec. 15 AstraZeneca (NYSE: ... Virginia (UVa) in Charlottesville, today announced that ... collaboration to enhance development of new treatments ... a secondary focus on peripheral vascular disease ... ,, The collaborative preclinical research projects will ...
(Date:12/15/2009)... -- The International Society for Medical Publication Professionals ... continuing to accept abstracts for its 6th Annual ... April 19-21, 2010. This marks the first time ... the organization to submit an abstract to this ... AM EST, January 15, 2010. For submission details, ...
(Date:12/15/2009)... PHILADELPHIA and LONDON, Dec. 15 ... Thomson Pharma ® has become the first ... trial protocol and outcome information. This highly anticipated ... Pharma customers this month. ,, ... trial intelligence from registries, publications, press releases, conferences, ...
Breaking Biology Technology:China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2
... Parion Sciences, Inc. today announced,that its partner, Gilead ... a Phase I,clinical trial of GS9411 in healthy ... investigational compound. GS9411 is designed to increase,airway ... Previously known as,P-680, GS9411 is an epithelial sodium ...
... its revolutionary Trusted LASIK Surgeons directory service and website ... resource for consumers seeking to improve their vision. What ... unique screening process ensuring that only those who are ... eye surgery in the United States are listed. ...
... the well-known dangers of first- and secondhand smoke, an estimated ... Exposure of a developing baby to harmful cigarette byproducts ... year and poses a significant health care burden. , Now, ... researchers has completed a global assessment of newborns, umbilical cord ...
Other Biology Technology:Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 2Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 3Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 4Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 5Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 6Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 7Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4
(Date:12/15/2009)... is a standard laboratory model organism, but there ... to analyze blood and blood-forming tissues in this ... and easy-to-use laboratory resources from Cold Spring Harbor ... Hematology features step-by-step protocols for the preparation, ... marrow, and other hematopoietic tissues in the mouse. ...
(Date:12/14/2009)... in a freeze-tolerant Alaska beetle able to survive temperatures ... biological antifreezes that contain protein, this new molecule, called ... of a sugar and a fatty acid and may ... , "The most exciting part of this discovery ... of antifreeze that may work in a different location ...
(Date:12/14/2009)... The most comprehensive study to date of the proteins ... may provide important clues to how similar regeneration could ... School of Science at Indiana University-Purdue University Indianapolis and ... limbs of axolotls, a type of salamander that has ... level of amputation, with the hope that this knowledge ...
Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2Scientists isolate new antifreeze molecule in Alaska beetle 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 1IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 2Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 1Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 2Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 380 Million European Runners Reveal Their Reasons to Run 55673 180 Million European Runners Reveal Their Reasons to Run 55673 280 Million European Runners Reveal Their Reasons to Run 55673 3
... respected as a world leader in scientific research, has ... being filled by foreign guest workers, but recent regulations ... S. have created a need for a new pool ... his colleagues at Texas A&M UniversityKingsville, the University of ...
... vegetables and fruits, color is one of the best ... color plays an important role in the business of ... example, color and color uniformity contribute directly to quality ... YSD, a ripening disorder that results in blotchy discoloration ...
... almost half as much particulate pollution into the air ... a new study. Ship pollutants affect both the Earth,s ... , The study is the first to provide ... air particle pollution based on direct measurements of emissions. ...
Other Biology News:Science internships attract students to research careers 2Color test enhances tomato analyzer software 2Commercial ships spew half as much particulate pollution as world's cars 2Commercial ships spew half as much particulate pollution as world's cars 3
Peptide Sequence: ovine COX-1 amino acids 272-282 (LMHYPRGIPPQ) To be used in conjunction with Cayman's COX-1 (ovine) polyclonal antiserum (Catalog No. 160108) to block protein-antibody complex f...
Anti-human VEGFR-1/Flt-1, clone Flt-1/EWI, Monoclonal Antibody...
Request Info...
Melanoma Antigen, Family C, 1 (MAGEC1) Rabbit anti-Human Polyclonal Antibody Immunogen: Synthetic peptide - KLH conjugated Family: New Recommended Storage: Long term: -20C; Short term: +4...
Biology Products: